Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Osiris Therapeutics Inc (NASDAQ:OSIR)

During the Trading Day
6.23 -0.16 / -2.50%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
6.23 +0.0012 / +0.02%
 
Volume: 1.5K

Today’s Trading

Previous close6.39
Today’s open6.30
Day’s range6.00 - 6.31
Volume120,416
Average volume (3 months)266,495
Market cap$220.2M
Dividend yield--
Data as of 4:00pm ET, 02/08/2016

Growth & Valuation

Earnings growth (last year)+78.54%
Earnings growth (this year)+260.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+146.29%
P/E ratio127.3
Price/Sales9.15
Price/Book2.61

Competitors

 Today’s
change
Today’s
% change
ENZYEnzymotec Ltd-0.22-2.24%
CBMGCellular Biomedicine...-1.51-8.48%
BTXBioTime Inc-0.06-2.74%
KMPHKemPharm Inc-2.87-20.00%
Data as of 4:02pm ET, 02/08/2016

Financials

Next reporting dateMarch 2, 2016
EPS forecast (this quarter)$0.06
Annual revenue (last year)$59.9M
Annual profit (last year)-$1.8M
Net profit margin-0.41%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer
Bobby Dwayne Montgomery
Chief Operating Officer
Frank D. Czworka
Corporate headquarters
Columbia, Maryland

Forecasts

Partner Offers